Group 1: Report Overview - The report focuses on the construction methods and performance of various ETF portfolios in November 2025, including macro-based, macro + momentum, core - satellite, and trinity style rotation portfolios [2] Group 2: ETF Portfolio Construction Methods Based on Macro Approach - Calculate macro - sensitivity of indices tracked by broad - based, industry - themed, and Smart Beta ETFs according to economic, liquidity, and credit variables, and select ETFs monthly. Also consider adding momentum indicators. Traditional cyclical industries are suitable for economic up - periods, TMT for weak - economic but liquid - abundant times, and consumption benefits from credit expansion. Three ETF portfolios are constructed and rebalanced monthly [5] Trinity Style Rotation - Build a mid - to long - term style rotation model centered on macro - liquidity, compared with the CSI 300 index. Combine three models (growth/value, market - cap, and quality) to get 8 style preference results, then screen target - style - exposed ETFs with controlled industry exposure and set allocation limits [6] Group 3: Macro Industry Portfolio - Select industry - themed ETFs with over 1 - year establishment and over 200 million current scale. Calculate sensitivity scores, adjust according to economic, liquidity, and credit indicators, and select the top 6 industry - themed indices. Currently, with economic indicators rising and liquidity/credit tightening, the portfolio turns to value with high bank and cyclical proportions. November holdings are mainly bank and energy - related ETFs, each with a 16.67% weight. The portfolio has large fluctuations and was close to the CSI 300 in October [7][9][11] Group 4: Macro + Momentum Industry Portfolio - Combine macro and momentum methods to address the left - side bias of macro - based strategies. Use clustering to select one product with the highest 6 - month gain from each of 6 industry - themed groups. The portfolio includes many pro - cyclical industries. November holdings have multiple ETFs, with weights like 16.67% for some and 8.33% for others. The portfolio performed well this year and was close to the CSI 300 in October [12][14][15] Group 5: Core - Satellite Portfolio - Designed to address the high volatility and fast industry rotation of industry - themed ETFs. Use the CSI 300 as the core. Construct three sub - portfolios (broad - based, industry, and Smart Beta) and combine them at 50%, 30%, and 20% respectively. November holdings are mainly mid - to large - cap biased. The portfolio performed steadily this year, outperforming the index almost every month, including in October [16][17][21] Group 6: Trinity Style Rotation ETF Portfolio - The model favors small - cap growth + high - quality segments this period. The portfolio's factor exposure and historical performance are provided. November holdings include ETFs such as Southern CSI 500 ETF and Southern CSI 1000 ETF. The portfolio had significant fluctuations in monthly returns and outperformed the index in most months this year, including in October [22][23][26]

Core Insights - The A-share market has shown significant recovery in 2025, with the Shanghai Composite Index reaching a 10-year high of 4025.70 points by the end of October, leading to a strong performance of public equity funds and the emergence of numerous "doubling funds" [1][3] Group 1: Fund Performance - The average net value growth rate of actively managed equity funds for the first ten months reached 27.48%, with the best-performing funds exceeding 200% [3][5] - Over 98% of actively managed equity funds reported positive net value growth rates, with 705 funds achieving over 50% growth, and 34 funds surpassing 100% [7][5] - The top-performing fund, Yongying Technology Smart Selection A, achieved a net value growth rate of 200.63%, capitalizing on opportunities in the cloud computing market [9][8] Group 2: Index and Sector Performance - Major indices such as the ChiNext Index and the Science and Technology Innovation 50 Index saw annual growth rates exceeding 50%, with the ChiNext Index at 48.84% [1][4] - The communication equipment sector emerged as a significant winner, with related index funds showing remarkable performance, including the Guotai CSI All-Index Communication Equipment ETF, which had a growth rate of 98.87% [12][13] Group 3: Investment Themes and Manager Insights - Fund managers are focusing on structural opportunities in sectors like AI, innovative drugs, and robotics, which have shown strong performance [7][14] - Investment strategies include a focus on domestic semiconductor equipment and energy storage, with managers highlighting the increasing production capacity of domestic storage chips and the growing demand for energy storage solutions [15][14]

Group 1: Report Information - Report Date: October 10, 2025 [1] - Report Title: Shenwan Hongyuan Gold ETF Portfolio 202510 [1] - Analysts: Shen Siyi, Deng Hu [3] - Research Support: Bai Haotian [3] - Contact: Shen Enyi [3] Group 2: Investment Ratings - No industry investment ratings are provided in the report. Group 3: Core Views - The report constructs four ETF portfolios, including the macro industry portfolio, macro + momentum industry portfolio, core - satellite portfolio, and trinity style rotation ETF portfolio, based on macro - sensitivity and momentum analysis, aiming to capture investment opportunities in different market environments [5][8]. - The current economic leading indicators are rising, liquidity indicators are slightly tight, and credit indicators remain positive. The portfolios are shifting towards a more balanced allocation, with an increased proportion of consumer sectors [5]. - The trinity style rotation model combines macro - liquidity, fundamental, and market sentiment factors to construct a medium - to long - term style rotation model, providing insights into market style preferences [5][9]. Group 4: ETF Portfolio Construction Methods 4.1 Based on Macro - Method - Calculate macro - sensitivity for broad - based, industry - theme, and Smart Beta ETFs based on economic, liquidity, and credit variables. Traditional cyclical industries are sensitive to the economy, TMT to liquidity, and consumption to credit [8]. - Construct three ETF portfolios (macro industry, macro + momentum industry, and core - satellite) using macro - sensitivity and momentum, and rebalance monthly [8]. 4.2 Trinity Style Rotation ETF Portfolio - Build a medium - to long - term style rotation model centered on macro - liquidity, comparing with the CSI 300 index. Screen macro, fundamental, and market sentiment factors to construct three types of models (growth/value, market - cap, and quality) [9]. Group 5: Portfolio Details 5.1 Macro Industry Portfolio - Select the top 6 industry - theme indices based on macro - sensitivity scores, and equally weight the largest - scale corresponding ETFs. Currently, the portfolio is more balanced with an increased consumer proportion [5][10]. - October 2025 holdings include ETFs related to tourism, home appliances, chemicals, etc. [14]. - In 2025, the portfolio had varying monthly excess returns, with positive excess returns in September [15]. 5.2 Macro + Momentum Industry Portfolio - Combine macro and momentum methods. The pharmaceutical sector's weight is further reduced, and rare earth and battery sectors are selected on the momentum side [5][16]. - October 2025 holdings include multiple industry - themed ETFs [18]. - The portfolio performed well in 2025, with positive excess returns in September after a drawdown in August [19]. 5.3 Core - Satellite Portfolio - Use the CSI 300 as the core and combine broad - based, industry, and Smart Beta portfolios. Weight them at 50%, 30%, and 20% respectively [20][21]. - October 2025 holdings include a mix of broad - based and industry - themed ETFs [24][25]. - The portfolio performed steadily in 2025, outperforming the index almost every month [25]. 5.4 Trinity Style Rotation ETF Portfolio - The model currently favors small - cap growth and high - quality styles. The portfolio's factor exposure and historical performance are presented [26][27]. - October 2025 holdings include ETFs related to small - cap indices and high - growth sectors [31]. - The portfolio has shown certain performance since 2021, with positive excess returns in September 2025 [30].

Core Viewpoint - The Hong Kong stock market experienced a pullback after reaching new highs, with the Hang Seng Index and Hang Seng Tech Index both declining, but there remains potential for upward movement, particularly in the technology sector [1][2][3]. Market Performance - As of October 8, the Hang Seng Index fell by 0.48% to 26,829.46 points, while the Hang Seng Tech Index decreased by 0.55% to 6,514.19 points [2]. - The Hang Seng Index had previously reached a year-to-date high of 27,381.84 points on October 2, marking a 1.61% increase on that day [2]. - Year-to-date, the Hang Seng Index and Hang Seng Tech Index have risen by 33.75% and 45.79%, respectively [4]. Fund Performance - Several Hong Kong-themed funds have shown outstanding performance, with some achieving returns of up to 155% in the first three quarters of the year [1][4]. - Specific funds, such as the Huatai-PineBridge Hong Kong Advantage Selected Mixed Fund, reported returns of 155.14% and 155.09% for different share classes, ranking third and fourth in the market [4]. Sector Focus - The technology sector, particularly in areas like AI and semiconductor industries, is expected to remain a focal point for investors, with a potential "volatile upward" trend led by industry leaders [1][5][6]. - The innovative pharmaceutical sector has also seen significant gains, with the China Securities Index tracking the Hong Kong Innovative Drug Index showing a year-to-date increase of 118.52% [4]. Future Outlook - Analysts suggest that the Hong Kong market still holds attractiveness due to its focus on core sectors like internet, innovative drugs, and medical biotechnology, with expectations for valuation recovery and capital inflow in the fourth quarter [5][6]. - The Hang Seng Index faces resistance above the 30,000-point mark, which historically has led to significant corrections, necessitating close monitoring of market movements [5].

Core Viewpoint - The Hong Kong stock market experienced a pullback after reaching new highs, with the Hang Seng Index and Hang Seng Tech Index both declining, but there remains potential for upward movement, particularly in the technology sector [1][3][4]. Market Performance - As of October 8, the Hang Seng Index fell by 0.48% to 26,829.46 points, while the Hang Seng Tech Index decreased by 0.55% to 6,514.19 points [3]. - The Hang Seng Index had previously reached a year-to-date high of 27,381.84 points on October 2, marking a 1.61% increase on that day [3]. - Year-to-date performance shows the Hang Seng Index and Hang Seng Tech Index have risen by 33.75% and 45.79%, respectively [5]. Fund Performance - Several Hong Kong-themed funds have performed exceptionally well, with some achieving returns of up to 155% in the first three quarters of the year [5]. - Specific funds, such as the Huatai-PineBridge Hong Kong Advantage Selected Mixed Fund, reported returns of 155.14% and 155.09% for different share classes [5]. Sector Focus - The technology sector, particularly in areas like AI, semiconductors, and innovative pharmaceuticals, is expected to remain a focal point for investors [4][6]. - The China A-share market's performance during the holiday period contributed to capital inflows into the Hong Kong market, leading to short-term gains [4]. Future Outlook - Analysts suggest that the Hong Kong market still has upward potential, especially if the Federal Reserve maintains a low-interest-rate environment and if Chinese assets remain relatively undervalued [4][6]. - The market is anticipated to continue its valuation recovery, with the technology sector being a key area of interest for future investments [6][7].

Core Viewpoint - The A-share and Hong Kong stock markets have shown a continuous upward trend since mid-April, achieving new highs in the third quarter, with equity funds yielding significant returns [1] Group 1: Active Equity Funds - A total of 37 funds have doubled their returns this year as of September 26, with 31 active equity funds in A-shares achieving over 100% returns [2][4] - The average return for active equity funds is 30.32%, with over 98% of these funds reporting positive returns [4] - The top-performing fund, Yongying Technology Smart Selection A, has a return rate of 189.58%, significantly boosted by its focus on AI concept stocks [4][6] Group 2: Passive Index Funds - Nearly 98% of index funds have achieved positive returns, with an average return of 27.53% [7] - Funds tracking innovative drugs, communications, and artificial intelligence have outperformed, with the top two funds yielding returns of 103.96% and 100.59% [7] - Underperforming index funds are primarily those tracking energy, food and beverage, and coal sectors, with losses exceeding 5% [7] Group 3: QDII Funds - QDII funds focused on the Hong Kong market, particularly in innovative drug assets, have performed well, with four funds exceeding 100% returns [3][8] - The top-performing QDII fund, Huatai Bairui Hang Seng Innovation Drug ETF, has a return of 152.25% [8] - Other notable funds in this category have also shown strong performance, with several exceeding 90% returns [8]

Core Viewpoint - The A-share market has shown significant strength in the first eight months of the year, leading to a strong performance of public equity funds, with many funds achieving over 100% returns [2][6][13]. Group 1: Market Performance - The main indices have experienced substantial gains, with the North Exchange 50 index rising by 51.49%, and several other indices, including the Sci-Tech Innovation 50 and the ChiNext index, increasing by over 30% [2][4]. - In August, the Shanghai Composite Index broke through the 3,800-point mark, reaching a 10-year high, with the Sci-Tech series indices showing strong performance, with increases of 32.25% and 28.00% respectively [4]. Group 2: Fund Performance - The average net value growth rate of active equity funds in the first eight months reached 23.83%, with the best-performing fund achieving a growth rate exceeding 175% [6][10][11]. - A total of 603 active equity funds have recorded a net value growth rate exceeding 50%, with 21 funds surpassing 100% [13][20]. - The average net value growth rates for ordinary stock funds and mixed equity funds were 28.38% and 28.79% respectively, indicating strong recovery in net values [9]. Group 3: Sector Opportunities - Structural opportunities have emerged in sectors such as the North Exchange, innovative pharmaceuticals, humanoid robots, AI, and semiconductors, contributing to the strong performance of funds managed by adept fund managers [12][20]. - The innovative pharmaceutical sector has been a standout performer, with the Hong Kong Stock Connect innovative pharmaceutical index showing a cumulative annual increase of 108.24% [24]. Group 4: Future Outlook - If the current market trends continue, 2025 is expected to be a breakout year for active equity fund performance [21]. - The market is experiencing a rebalancing of underlying funds, with indications of capital flowing from dollar assets to non-dollar assets, and from the bond market to the equity market [26].

Group 1 - The innovative drug sector has been actively rising since the end of July, with significant increases in various sub-concept indices [1] - A substantial amount of capital has flowed into the innovative drug field through ETFs, with a total net inflow of 7.551 billion yuan in August [1] - 24 innovative drug ETFs, including QDII, have recorded gains in August, with nearly 80% of them experiencing net inflows [1] Group 2 - The Huatai-PineBridge Hong Kong Innovative Drug ETF saw a net inflow of 2.829 billion yuan in August, leading the sector [1] - The GF CSI Hong Kong Innovative Drug ETF followed closely with a net inflow of 2.711 billion yuan [1] - Other ETFs such as the Hong Kong Innovative Drug ETF, Invesco Great Wall CSI Hong Kong Innovative Drug ETF, and GF Innovative Drug ETF also reported significant net inflows [1]

Group 1 - The A-share market indices have recently reached new highs, leading to increased attention on ETFs, with trading volumes exceeding 400 billion yuan on several days [1] - The overall ETF market saw significant trading activity, with daily trading volumes of 410.5 billion yuan, 435.1 billion yuan, and nearly 493 billion yuan over three consecutive days [1] - A total of 15 broad-based ETFs had average daily trading volumes exceeding 1 billion yuan during this period, with notable performances from specific ETFs like Huaxia's STAR Market 50 ETF and the CSI A500 ETF [1] Group 2 - The average return of funds this year is 10.44%, while ETFs have performed better with an average return of 15.51%, with several ETFs exceeding 100% returns [2] - Analysts suggest a "core-satellite" strategy for asset allocation, where broad-based index funds serve as the main investment, while specific industry index funds are allocated as satellite positions [2] - The growth of stock ETFs contrasts with active equity funds, highlighting the diverse applications of ETFs in asset allocation and strategy [3]

Group 1 - As of July 31, 12 public funds have achieved a net value growth rate exceeding 100% in 2023, primarily focusing on themes such as innovative drugs, biomedicine, and healthcare, closely linked to the strong performance of the Hong Kong innovative drug sector [1][2] - The top-performing fund, Huatai-PB Hong Kong Advantage Selection A, boasts a 143.24% year-to-date net value growth rate, heavily invested in Hong Kong innovative drugs, with its top ten holdings all being Hong Kong innovative drug stocks [2][3] - Other notable funds with over 100% growth include Changcheng Medical Industry Selection A and Bank of China Hong Kong Stock Connect Medical A, along with several ETFs focused on innovative drugs [2][3] Group 2 - The strong performance of the Hong Kong innovative drug sector is driven by three main factors: increased collaboration needs due to multinational pharmaceutical companies facing "patent cliffs," many biotech companies approaching breakeven within three to five years, and comprehensive policy support from research to payment [3] - The manager of Huatai-PB Hong Kong Stock Connect Innovative Drug ETF noted a significant acceleration in Chinese innovative drug companies' overseas expansion since 2025, with multiple large overseas licensing deals indicating global recognition of China's innovation capabilities [3] - The manager of Huatai-PB Hong Kong Advantage Selection Mixed Fund emphasized that with the recovery of market risk appetite, innovative drug companies with core competitiveness will demonstrate long-term growth value, focusing on globally competitive innovative drug firms and high-quality medical device leaders [3] Group 3 - The Hong Kong stock market has seen significant liquidity improvement and increased trading activity in 2023, enhancing its resilience and attracting global capital to quality assets [4] - The Hang Seng Index has outperformed major global markets with over a 20% increase in the first half of the year, and net inflows from southbound funds exceeded 700 billion yuan, marking a record high [4] - Looking ahead, the Hong Kong market is expected to continue its diversification trend, supported by improving free cash flow and increasing share buybacks among listed companies, which may lay a solid foundation for long-term stable performance [4]